9th Circ. Won't Touch FCA Suit Over Off-Label Opioids
The Ninth Circuit on Thursday refused to revive a False Claims Act suit accusing Janssen Pharmaceutica NV of boosting off-label sales of its opioid prescription drugs with unlawful marketing practices, finding...To view the full article, register now.
Already a subscriber? Click here to view full article